These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7544611)

  • 1. Maternal serum screening for Down's syndrome in the first trimester of pregnancy.
    Biagiotti R; Cariati E; Brizzi L; D'Agata A
    Br J Obstet Gynaecol; 1995 Aug; 102(8):660-2. PubMed ID: 7544611
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved antenatal screening for Down's syndrome.
    Benn P
    Lancet; 2003 Mar; 361(9360):794-5. PubMed ID: 12642040
    [No Abstract]   [Full Text] [Related]  

  • 10. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester screening for Down's syndrome in in vitro fertilization pregnancies.
    Niemimaa M; Heinonen S; Seppälä M; Hippeläinen M; Martikainen H; Ryynänen M
    Fertil Steril; 2001 Dec; 76(6):1282-3. PubMed ID: 11730770
    [No Abstract]   [Full Text] [Related]  

  • 12. False positivity of prenatal Down's syndrome and neural-tube tests in SLE.
    La Montagna G; Baruffo A; Buono G; Tirri R
    Lancet; 2000 Sep; 356(9236):1194-5. PubMed ID: 11030323
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum screening for Down's syndrome.
    Bibby J; McCormack MJ
    Br J Obstet Gynaecol; 1994 Jun; 101(6):557-8. PubMed ID: 7517183
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of hydatidiform mole in maternal serum screening programmes for Down's syndrome.
    Cuckle HS; Densem JW; Wald NJ
    Br J Obstet Gynaecol; 1992 Jun; 99(6):495-7. PubMed ID: 1379065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Down's screening test associated with severe hyperemesis gravidarum.
    Pradhan P; Mohajer M
    J Obstet Gynaecol; 2002 Nov; 22(6):692. PubMed ID: 12554274
    [No Abstract]   [Full Text] [Related]  

  • 17. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of the triple test in the diagnosis of Down's syndrome.
    Mol BW; Lok JJ; Voorn W; Pajkrt E; van Lith J; van der Meulen J
    Early Hum Dev; 1996 Dec; 47 Suppl():S55-8. PubMed ID: 9031842
    [No Abstract]   [Full Text] [Related]  

  • 20. First trimester screening for Down's syndrome using maternal serum PAPP-A and free beta-hCG in combination with fetal nuchal translucency thickness.
    Biagiotti R; Brizzi L; Periti E; d'Agata A; Vanzi E; Cariati E
    Br J Obstet Gynaecol; 1998 Aug; 105(8):917-20. PubMed ID: 9746387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.